US OptionsDetailed Quotes
CLOV250509P3000
- 0.01
- 0.000.00%
15min DelayClose May 9 12:43 ET
0.00High0.00Low
0.00Open0.01Pre Close0 Volume6.09K Open Interest3.00Strike Price0.00Turnover9018.91%IV9.67%PremiumMay 9, 2025Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0610Delta0.3306Gamma331.00Leverage Ratio-43.7532Theta0.0000Rho-20.18Eff Leverage0.0000Vega
Clover Health Stock Discussion
Clover Health Earnings Show Massive Turnaround: Revenue Up 33%, Medicare Members Surge 30%
•First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year
•First quarter 2025 Total revenues of $462 million, up 33% year-over-year
•Medicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’s technology-first care management model
•Meaningful improvement across first quarter 2025 profitability metrics:
◦GA...
Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...
Healthcare AI Breakthrough: Clover's Counterpart Assistant Lands Major Hospital System Deal
4 MINUTES AGO, 9:00 AM EST
VIA GLOBENEWSWIRE
No comment yet